Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference44 articles.
1. CTLA-4: new insights into its biological function and use in tumor immunotherapy;Egen;Nat Immunol,2002
2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
3. Immunostimulatory monoclonal antibodies for cancer therapy;Melero;Nat Rev Cancer,2007
4. Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases;Kwon;Exp Mol Med,2003
5. TNF/TNFR family members in costimulation of T cell responses;Watts;Annu Rev Immunol,2005
Cited by 244 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production;Frontiers in Immunology;2024-03-07
2. Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics;Journal of Biotechnology;2023-11
3. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects;Science Advances;2023-08-18
4. Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications;Frontiers in Immunology;2023-08-17
5. Immunotherapy for Pancreatic Cancer;The Pancreas;2023-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3